bioRxivBioinformaticsPreprint
Extending the Boundaries of Cancer Therapeutic Complexity with Literature Data Mining
Danna NiezniiD, Hillel Taub-Tabib, Yuval HarrisiD, Hagit Sason, Yakir Amrusi, Dana Meron Azagury, Maytal AvrashamiiD, Shaked Launer-Wachs, Jon Borchardt, M. Kusold, Aryeh Tiktinsky, Tom HopeiD, Yoav GoldbergiD, Yosi ShamayiD
Abstract
Drug combination therapy is a main pillar of cancer therapy but the formation of an effective combinatorial standard of care (SOC) can take many years and its length of development is increasing with complexity of treatment. In this paper, we develop a path to extend the boundaries of complexity in combinatorial cancer treatments using text data mining (TDM). We first use TDM to characterize the current boundaries of cancer treatment complexity and find that the current complexity limit for clinical trials is 6 drugs per plan and for pre-clinical research is 10. We then present a TDM based assistive technology, cancer plan builder (CPB), which we make publicly available and allows experts to create literature-anchored high complexity combination treatment (HCCT) plans of significantly larger size. We develop metrics to evaluate HCCT plans and show that experts using CPB are able to create HCCT plans at much greater speed and quality, compared to experts without CPB. We hope that by releasing CPB we enable more researchers to engage with HCCT planning and demonstrate its clinical efficacy.
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DrugCombDB: a comprehensive database of drug combinations toward network medicine and combination therapy
- DrugComb - an integrative cancer drug combination data portal
B. Zagidullin, J. Aldahdooh, … J. Tang·bioRxiv·Feb 25, 2019
- The Landscape of Receptor-Mediated Precision Cancer Combination Therapy: A Single-Cell Perspective
Saba Ahmadi, Pattara Sukprasert, … Eytan Ruppin·bioRxiv·Jan 28, 2020
- Cancer drug discovery as a low rank tensor completion problem
V. Siruvallur Murali, D. Agac Cobanoglu, … M. C. Cobanoglu·bioRxiv·Mar 8, 2021
- Explainable machine learning prediction of synergistic drug combinations for precision cancer medicine
Joseph D. Janizek, Safiye Celik, Su-In Lee·bioRxiv·May 27, 2018
- CombiCTx: Screening diffusion gradients of anti-cancer drug combinations
Christina Stelzl, Ada Lerma Clavero, … Paul W. O'Callaghan·Lab on a ChipPeer-reviewed·Jan 1, 2026